
Libcef SB 1000mg/500mg Injection
Marketer
DR. LBR Medi Care & Research Private Limited
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Libcef SB 1000mg/500mg Injection
Cefixime and Sulbactam 1000mg/500mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and progression. Administration must be under a doctor's direction; strictly adhere to the prescribed dosage schedule. Complete the entire treatment course, even with symptom improvement; premature cessation can compromise effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report any worsening symptoms promptly. Seek immediate medical attention for allergic reactions like rash, itchiness, swelling, or breathing difficulties. Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or nursing individuals should consult their doctor before use. Alcohol should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration contribute to faster recovery. Your physician might order tests to monitor the medication's effects.
Uses of Libcef SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Libcef SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Libcef SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Libcef SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Libcef SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Libcef SB 1000mg/500mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The inclusion of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Libcef SB 1000mg/500mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Libcef SB, at a dose of 1000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful effects on fetal development; nonetheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Libcef SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Libcef SB 1000mg/500mg Injection could lead to drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Libcef SB 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Libcef SB 1000mg/500mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Libcef SB 1000mg/500mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Libcef SB 1000mg/500mg Injection :
Omit doses of Libcef SB 1000mg/500mg Injection only after contacting your physician.
Facts to Know About Libcef SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
